Välkommen till Via TT - det enkla pressverktyget

Well positioned for sustainable growth with optimized network and enhanced processes

The Council on Ethics for the Swedish National Pension Funds sums up a year of active engagement. The proactive work addresses important systemic issues, including antimicrobial resistance and the extraction of critical metals and minerals for the green transition. The outcomes during 2024 also show continued progress in the reactive company dialogues.

With high stakes in the World Cup standings and a historic venue setting the stage, riders shared their thoughts on pressure, past victories, and the road ahead.

The year 2024 was impacted by the strong US economy and new record levels in the US stock markets. Easing inflationary pressures and weaker real economic growth prompted more central banks to cut policy rates in 2024 than the world has seen in many years. Through a carefully considered portfolio positioning and focused execution, Första AP-fonden's return landed at 9.9%.

Four six-year-olds and an equal number of seven-year-olds competed in the SWB Trophy presented by Hyperion. In the end, it was Soretto, ridden by Yvonne Österholm, and Vidar, ridden by Anna Svanberg, who earned the highest scores.

Revenue grew 3 percent on a comparable basis to €18.4 billion (Q1 2024: €17.7 billion) Orders in Q1 2025 declined 8 percent on a comparable basis to €20.1 billion (Q1 2024: €21.6 billion) Profit Industrial Business totaled €2.5 billion (Q1 2024: €2.7 billion); profit margin Industrial Business was 14.1 percent (Q1 2024: 15.8 percent) Free cash flow at Group level rose sharply to €1.6 billion (Q1 2024: €1.0 billion) Net income soared 52 percent to €3.9 billion (Q1 2024: €2.5 billion), benefiting from a €2.1 billion gain (after tax) from the sale of Innomotics Outlook for fiscal 2025 confirmed Virtual Annual Shareholders’ Meeting to vote on dividend proposal of €5.20 per share for fiscal 2024 (fiscal 2023: €4.70)

Q3 sales at previous year’s level and adjusted EBITDA margin improves significantly to 9.2 percent Incoming orders up 8.3 percent for Q3 and 7.7 percent after nine months compared with previous year High order backlog points to strong final quarter Full-year forecast confirmed, adjusted EBITDA margin to rise to up to around 8 percent in FY 2025/2026 Packaging remains a growth driver Growth strategy promises sales potential of over € 300 million in medium term

SBAB Bank AB (publ) (”SBAB”) meddelar att man kommer att genomföra en förtida inlösen av samtliga utestående primärkapitalinstrument (AT1) emitterade den 5 september 2019 med ISIN SE0012193787, med ett totalt utestående nominellt belopp om 400 000 000 kronor (”Obligationerna”) i enlighet med villkoren för Obligationerna (”Obligationsvillkoren”).

Prosecutors have today requested the Stockholm District Court to detain a Swedish citizen suspected of severe war crimes and terrorist crimes in Syria.

Growth strategy: medium-term sales potential of more than € 300 million Growth drivers in the core business: packaging, digital printing Software and lifecycle business Industrial business: focus on further expansion 175 years: the company has been shaping the printing industry for decades with technological innovations, quality and reliability Numerous anniversary activities throughout the year

As part of the EU-funded APRIORA project, drug residues are being analysed. Scientists from the University of Rostock are taking water samples in all weathers. The aim is to use innovative approaches to improve wastewater treatment in Europe.

The second session of the General Synod with debates and decision-making is now closed.

A clear majority of Europeans are willing to take greater responsibility for their own interests in a changing world order. This is the key finding of an eupinions survey conducted by the Bertelsmann Stiftung in the 27 member states of the European Union. The figures show a clear shift in opinion in Europe: at the end of 2017, only a quarter of citizens wanted more European engagement.

• 55% of Azerbaijani respondents say that the energy transition is a priority, in line with European countries • 64% of Azerbaijani respondents (more than the United Arab Emirates, Saudi Arabia and India) and 53% in Kazakhstan (more than Italy, the United Kingdom, the United States and China itself) consider energy transition crucial to combat climate change • Energy transition training and professional development are crucial issues in both Kazakhstan and Azerbaijan for over 80% of those interviewed, more than in India (71%), USA and Saudi Arabia (75%) • The study covers 12 countries in 4 continents for a total of over 2,000 interviews carried out by IPSOS, an international market research company

The General Synod is the highest decision-making body of the Church of Sweden, deciding on issues common to the entire Church of Sweden. This year’s theme, ‘The Church in the Public Space’, addresses the place of the church in society, locally and globally.

Incoming orders after six months above previous year’s level thanks to strong drupa orders High order backlog provides sound basis for projected sales volume in second half of the year, capacities being fully utilized Strong seasonality in financial year, with sales and EBITDA in the first half of the year within expectations Packaging solutions segment remains growth driver Annual forecast confirmed

Le Prix Edelstam 2024 est décerné à M. Dawit Isaak pour ses contributions exceptionnelles et son courage remarquable à défendre la liberté d'expression, ses convictions et les droits de l'homme. Le prix sera remis lors d'une cérémonie à la Maison de la Noblesse à Stockholm, en Suède, le 19 novembre 2024. Étant donné que Dawit Isaak est un prisonnier d'opinion et le journaliste détenu le plus longtemps au monde, il ne pourra pas être présent. Sa fille, Betlehem Isaak, recevra le prix en son nom.

The Phase III trial AV001 aims to evaluate QUTENZA® in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical procedures[1], thus affecting more than 3 million people with surgical procedures per year in the U.S.[2] QUTENZA® is a topical system, non-systemic, non-opioid pain treatment that is currently approved in the US for the treatment of neuropathic pain associated with postherpetic neuralgia (PHN) and neuropathic pain associated with diabetic peripheral neuropathy (DPN) of the feet in adults. Topline results are expected in Q4 2025 and Averitas Pharma aims to submit a supplemental new drug application (sNDA) for a US label extension in 2026, subject to positive data.

QUARTERLY RESULT Today, If P&C Insurance presented continued solid financial results for the third quarter and first nine months of 2024. If’s Nordic scale continues to deliver advantages in balancing risk and reducing costs, and will increase further with the upcoming integration of Topdanmark.

20 years of applied digitalization and 5 years of experience with AI HEIDELBERG has been networking machines and systems in print shops since 2004 13,000 units worldwide are connected to the HEIDELBERG Cloud Three-digit million euro amount for digital processes, products and services